Lonza Amaxa 4D-Nucleofector system
The Amaxa Nucleofector technology is claimed to be the first efficient non-viral transfection method for primary cells and hard-to-transfect cell lines.
With a new platform, the 4D-Nucleofector system enables nucleofection of cells in several formats, combined with good performance and convenience.
Its features include: transfection of variable cell numbers with same conditions; choice of throughputs from 1 to 16 wells in just 10 s; nucleofection of adherent cells for functional assays at various cellular stages.
The modular system will accommodate upcoming transfection challenges and a current transfection protocol database is available with 690 cells listed, which is continuously updated.
Phone: 1300 657508
Dojindo Laboratories ExoIsolator Exosome Isolation Kit
The ExoIsolator Exosome Isolation Kit, from Dojindo Laboratories, can collect exosomes...
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...
Learn More
I am interested in Lonza Amaxa 4D-Nucleofector system.
Complete the form and a supplier representative will be in touch.
